Joe Rogan Experience #2576 - Dr. Peter McCullough · Aired Nov 4, 2026
Claim summary · not a verbatim quotation
McCullough says Evusheld is currently approved for post-exposure prevention.
The finding
What the evidence shows
FDA authorized Evusheld for pre-exposure prevention, expressly excluding post-exposure use. It was an EUA, not full approval. FDA's archive also records loss of authorization against circulating variants and revocation.
Read the supporting source · www.fda.gov ↗Quick answer & review status
Quick answer
Is it true that McCullough says Evusheld is currently approved for post-exposure prevention?
No, not as stated. FDA authorized Evusheld for pre-exposure prevention, expressly excluding post-exposure use. It was an EUA, not full approval. Dr. Peter McCullough said it (matched by voice) on Joe Rogan Experience #2576 - Dr. Peter McCullough, aired Nov 4, 2026, at 1:26:07. The supporting source is fda.gov, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.